Yorktown Management & Research Co Inc decreased its stake in Abiomed Inc. (ABMD) by 50.49% based on its latest 2018Q1 regulatory filing with the SEC. Yorktown Management & Research Co Inc sold 2,600 shares as the company’s stock rose 44.33% while stock markets declined. The institutional investor held 2,550 shares of the health care company at the end of 2018Q1, valued at $742,000, down from 5,150 at the end of the previous reported quarter. Yorktown Management & Research Co Inc who had been investing in Abiomed Inc. for a number of months, seems to be less bullish one the $19.73B market cap company. The stock increased 0.66% or $2.93 during the last trading session, reaching $443.58. About 498,364 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 190.17% since June 17, 2017 and is uptrending. It has outperformed by 177.60% the S&P500. Some Historical ABMD News: 04/04/2018 – ABIOMED ANNOUNCES EUROPEAN APPROVAL (CE MARKING) FOR IMPELLA 5.5™ AND FIRST PATIENT TREATED AT UNIVERSITY HEART CENTER HAMBURG; 03/04/2018 – Opsens Technology Receives FDA Approval in Abiomed’s Impella Cardiac Pump; 02/04/2018 – Abiomed Receives FDA Approval for Impella CP(R) With SmartAssist(TM) and Optical Sensor; 02/04/2018 – Abiomed Receives FDA Approval for lmpella CP® with SmartAssist™ and Optical Sensor; 03/05/2018 – ABIOMED 4Q REV. $174.4M, EST. $164.4M; 16/05/2018 – Abiomed May Face Pressure, Industry Posts 17th Straight Drop; 03/05/2018 – Abiomed 4Q EPS 80c; 02/04/2018 – ABIOMED GETS FDA APPROVAL FOR IMPELLA CP® WITH SMARTASSIST™ & O; 03/05/2018 – Abiomed Sees FY19 Rev $740M-$770M; 03/05/2018 – ABIOMED SEES FY REV. $740.0M TO $770.0M, EST. $747.3M
Albion Financial Group decreased its stake in Realpage Inc. (RP) by 30.46% based on its latest 2018Q1 regulatory filing with the SEC. Albion Financial Group sold 7,034 shares as the company’s stock rose 16.19% while stock markets declined. The institutional investor held 16,058 shares of the technology company at the end of 2018Q1, valued at $827,000, down from 23,092 at the end of the previous reported quarter. Albion Financial Group who had been investing in Realpage Inc. for a number of months, seems to be less bullish one the $5.40B market cap company. The stock increased 0.08% or $0.05 during the last trading session, reaching $59.95. About 485,218 shares traded. RealPage, Inc. (NASDAQ:RP) has risen 70.85% since June 17, 2017 and is uptrending. It has outperformed by 58.28% the S&P500. Some Historical RP News: 20/04/2018 – REALPAGE -ERNEST MULLER & TOM KIERNAN, CHAIRMAN AND CEO OF CLICKPAY, RESPECTIVELY, WILL REMAIN WITH BUSINESS IN ADDITION TO ABOUT 100 EMPLOYEES; 21/05/2018 – RealPage Announces Proposed Follow-on Public Offering of Common Stk; 03/05/2018 – REALPAGE 1Q ADJ EPS 37C, EST. 34C; 03/05/2018 – RealPage 1Q EPS 13c; 29/03/2018 RealPage® Reports Cooling in the U.S. Apartment Market Performance During the First Quarter’s Slow Leasing Period; 17/04/2018 – Single Family Housing Leader HomeRiver Group Selects RealPage’s Propertyware Platform; 20/04/2018 – REALPAGE – EXPECTS TO ACHIEVE REV AND EXPENSE SYNERGIES FROM DEAL THAT WILL BE ACCRETIVE TO LONG-TERM REV GROWTH, ADJ EBITDA MARGIN EXPANSION OBJECTIVES; 17/04/2018 – Single Family Housing Leader HomeRiver Group Selects RealPage’s Propertyware Platform; 10/04/2018 – RealPage’s Propertyware Division Launches Asset Protection Plan and Cash Payments; 10/05/2018 – Seattle-Based Property Manager Blanton Turner to Switch Entire Portfolio to RealPage Software
Investors sentiment increased to 1.08 in Q1 2018. Its up 0.28, from 0.8 in 2017Q4. It is positive, as 18 investors sold RP shares while 72 reduced holdings. 42 funds opened positions while 55 raised stakes. 62.63 million shares or 3.29% more from 60.64 million shares in 2017Q4 were reported. Millennium Mgmt Limited Liability Com has 0% invested in RealPage, Inc. (NASDAQ:RP). Massmutual Trust Co Fsb Adv has 0% invested in RealPage, Inc. (NASDAQ:RP) for 10,421 shares. Dorsey Whitney Trust Co Lc holds 4,472 shares or 0.04% of its portfolio. Kornitzer Ks has 69,510 shares for 0.06% of their portfolio. Martingale Asset Management LP invested in 0% or 7,200 shares. Bridgeway Capital Mgmt reported 0.01% in RealPage, Inc. (NASDAQ:RP). Sheets Smith Wealth Mgmt holds 28,568 shares or 0.35% of its portfolio. Amer Capital holds 2.08% or 710,196 shares. 6,458 are held by Jefferies. Cwm accumulated 0% or 12 shares. Palisade Cap Mgmt Ltd Liability Corporation Nj holds 1.25% or 715,190 shares. Stephens Inc Ar holds 0.1% in RealPage, Inc. (NASDAQ:RP) or 51,160 shares. Tower Rech Cap Ltd Limited Liability Company (Trc) owns 8,621 shares. Albion Financial Grp Inc Ut invested 0.13% in RealPage, Inc. (NASDAQ:RP). State Street holds 1.14 million shares or 0.01% of its portfolio.
Since January 3, 2018, it had 0 insider buys, and 21 sales for $212.26 million activity. On Wednesday, January 3 WINN STEPHEN T sold $9.19 million worth of RealPage, Inc. (NASDAQ:RP) or 201,968 shares. 8,000 shares were sold by HILL W BRYAN, worth $468,240. Chaney William P sold 5,000 shares worth $265,250. Monk David G also sold $428,800 worth of RealPage, Inc. (NASDAQ:RP) on Friday, March 9. Shares for $211,440 were sold by BERKELEY ALFRED R III on Wednesday, March 7. Blount Andrew had sold 56,250 shares worth $2.88M.
Among 7 analysts covering RealPage (NASDAQ:RP), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. RealPage had 22 analyst reports since June 8, 2016 according to SRatingsIntel. The stock has “Hold” rating by RBC Capital Markets on Wednesday, January 17. The rating was upgraded by Morgan Stanley on Tuesday, January 30 to “Overweight”. The rating was upgraded by William Blair to “Outperform” on Wednesday, June 8. The rating was maintained by Deutsche Bank with “Buy” on Thursday, August 3. The company was maintained on Thursday, August 3 by Stephens. As per Monday, February 5, the company rating was maintained by KeyBanc Capital Markets. The firm has “Buy” rating by Deutsche Bank given on Tuesday, July 18. The stock has “Buy” rating by Stephens on Wednesday, February 28. The stock of RealPage, Inc. (NASDAQ:RP) earned “Hold” rating by RBC Capital Markets on Sunday, September 10. RBC Capital Markets maintained RealPage, Inc. (NASDAQ:RP) rating on Sunday, July 23. RBC Capital Markets has “Hold” rating and $3800 target.
Albion Financial Group, which manages about $833.04 million and $650.39M US Long portfolio, upped its stake in Lockheed Martin Corp. (NYSE:LMT) by 1,279 shares to 15,267 shares, valued at $5.16 million in 2018Q1, according to the filing. It also increased its holding in Jpmorgan Chase & Co (NYSE:JPM) by 11,026 shares in the quarter, for a total of 133,087 shares, and has risen its stake in Ishares Core S&P Small (IJR).
Analysts await RealPage, Inc. (NASDAQ:RP) to report earnings on August, 1. They expect $0.25 EPS, up 92.31% or $0.12 from last year’s $0.13 per share. RP’s profit will be $22.53M for 59.95 P/E if the $0.25 EPS becomes a reality. After $0.28 actual EPS reported by RealPage, Inc. for the previous quarter, Wall Street now forecasts -10.71% negative EPS growth.
Among 15 analysts covering Abiomed (NASDAQ:ABMD), 12 have Buy rating, 0 Sell and 3 Hold. Therefore 80% are positive. Abiomed had 36 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was maintained by SunTrust with “Buy” on Friday, February 16. As per Tuesday, June 6, the company rating was maintained by Jefferies. The rating was maintained by Piper Jaffray with “Hold” on Wednesday, August 5. Piper Jaffray maintained the stock with “Buy” rating in Thursday, February 1 report. On Wednesday, December 7 the stock rating was initiated by Guggenheim with “Buy”. The company was maintained on Tuesday, August 4 by BTIG Research. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Buy” rating by Jefferies on Thursday, August 3. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Outperform” rating by Raymond James on Friday, October 30. On Thursday, June 8 the stock rating was reinitiated by William Blair with “Buy”. SunTrust initiated ABIOMED, Inc. (NASDAQ:ABMD) on Friday, September 29 with “Buy” rating.
Since February 20, 2018, it had 0 buys, and 5 sales for $31.65 million activity. Greenfield Andrew J sold $5.41 million worth of stock. SUTTER MARTIN P also sold $7.52 million worth of ABIOMED, Inc. (NASDAQ:ABMD) on Tuesday, May 8. On Monday, May 7 the insider Howley Michael G sold $6.09M. $4.70M worth of ABIOMED, Inc. (NASDAQ:ABMD) was sold by PUHY DOROTHY E on Monday, May 7.
Analysts await ABIOMED, Inc. (NASDAQ:ABMD) to report earnings on July, 26. They expect $0.80 EPS, up 77.78% or $0.35 from last year’s $0.45 per share. ABMD’s profit will be $35.58M for 138.62 P/E if the $0.80 EPS becomes a reality. After $0.80 actual EPS reported by ABIOMED, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
Yorktown Management & Research Co Inc, which manages about $931.40M and $337.68 million US Long portfolio, upped its stake in Ladder Capital Corp. (NYSE:LADR) by 120,000 shares to 370,000 shares, valued at $5.58M in 2018Q1, according to the filing. It also increased its holding in United Parcel Service Inc. (NYSE:UPS) by 3,000 shares in the quarter, for a total of 25,000 shares, and has risen its stake in Metlife Inc. (NYSE:MET).
More notable recent ABIOMED, Inc. (NASDAQ:ABMD) news were published by: Globenewswire.com which released: “Abiomed to Present at the Jefferies 2018 Healthcare Conference” on May 29, 2018, also Seekingalpha.com with their article: “Discovery Is Undervalued – Cramer’s Lightning Round (6/11/18)” published on June 12, 2018, Investorplace.com published: “7 A-Rated Stocks to Buy for the Second Half of 2018” on June 08, 2018. More interesting news about ABIOMED, Inc. (NASDAQ:ABMD) were released by: Benzinga.com and their article: “Benzinga’s Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid …” published on June 15, 2018 as well as Seekingalpha.com‘s news article titled: “PRAH +3% on MidCap 400 move; ABMD to S&P 500” with publication date: May 25, 2018.